REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER | Return to index | ||||||||
Order | Gene | Description | ref_hepatocyte | HepG2 | HepG2.C3A | HuH.7 | SNU475 | THLE | liver |
1 | CDKN1A | Cyclin-dependent kinase inhibitor 1 | [1] | 0.36[2] | -1.30[3] | -3.53[4] | -2.07[5] | 0.03[6] | -2.19[7] |
2 | AKT1 | RAC-alpha serine/threonine-protein kinase | [8] | -0.40[9] | -0.90[10] | -1.52[11] | -0.13[12] | -0.56[13] | -0.60[14] |
3 | MAPKAP1 | Target of rapamycin complex 2 subunit MAPKAP1 | [15] | -0.49[16] | -1.01[17] | -0.33[18] | 0.00[19] | -0.27[20] | -0.54[21] |
4 | RPS6KB2 | Ribosomal protein S6 kinase beta-2 | [22] | [23] | [24] | [25] | [26] | [27] | [28] |
5 | BAD | Bcl2-associated agonist of cell death | [29] | -2.15[30] | -2.29[31] | -2.78[32] | -1.15[33] | -1.20[34] | -1.78[35] |
6 | AKT1S1 | Proline-rich AKT1 substrate 1 | [36] | -0.94[37] | -1.37[38] | -0.56[39] | -0.83[40] | -0.66[41] | -1.55[42] |
7 | CDKN1B | Cyclin-dependent kinase inhibitor 1B | [43] | -0.56[44] | -0.39[45] | 0.26[46] | -1.19[47] | -1.18[48] | -1.27[49] |
8 | AKT2 | RAC-beta serine/threonine-protein kinase | [50] | 0.48[51] | 0.49[52] | 1.07[53] | 0.78[54] | 0.12[55] | 0.77[56] |
9 | MLST8 | Target of rapamycin complex subunit LST8 | [57] | -0.65[58] | -0.59[59] | 0.23[60] | -1.06[61] | -1.16[62] | -0.92[63] |
10 | GSK3A | Glycogen synthase kinase-3 alpha | [64] | 0.14[65] | -0.39[66] | 0.17[67] | 0.00[68] | 0.31[69] | -2.19[70] |
11 | PRR5 | Proline-rich protein 5 | [71] | -1.07[72] | -1.28[73] | -1.74[74] | -2.37[75] | -5.61[76] | -1.14[77] |
12 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | [78] | 1.63[79] | 2.78[80] | 0.47[81] | 0.43[82] | 0.85[83] | 1.80[84] |
13 | GSK3B | Glycogen synthase kinase-3 beta | [85] | 0.79[86] | 0.15[87] | 1.18[88] | 1.73[89] | 1.11[90] | 0.80[91] |
14 | CHUK | Inhibitor of nuclear factor kappa-B kinase subunit alpha | [92] | 0.42[93] | 1.37[94] | 1.79[95] | 0.57[96] | 0.93[97] | 1.16[98] |
15 | PDPK1 | 3-phosphoinositide-dependent protein kinase 1 | [99] | 1.85[100] | 2.77[101] | 1.94[102] | 1.36[103] | 1.30[104] | 2.14[105] |
16 | MTOR | Serine/threonine-protein kinase mTOR | [106] | 2.06[107] | 2.80[108] | 2.82[109] | 2.60[110] | 2.23[111] | 3.09[112] |
17 | TSC2 | Tuberin | [113] | 1.34[114] | 0.59[115] | 1.74[116] | 1.12[117] | 1.19[118] | 1.72[119] |
18 | FOXO3 | Forkhead box protein O3 | [120] | -0.02[121] | -0.20[122] | 0.89[123] | 0.32[124] | 1.10[125] | 1.97[126] |
19 | CASP9 | Caspase-9 | [127] | -0.32[128] | 0.37[129] | -0.06[130] | 0.17[131] | -0.97[132] | -0.90[133] |
20 | CREB1 | Cyclic AMP-responsive element-binding protein 1 | [134] | 1.24[135] | 2.13[136] | 3.08[137] | 2.46[138] | 1.95[139] | 1.98[140] |
21 | FOXO1 | Forkhead box protein O1 | [141] | 1.21[142] | 0.61[143] | 1.20[144] | 1.09[145] | 2.66[146] | 2.73[147] |
22 | RICTOR | Rapamycin-insensitive companion of mTOR | [148] | 0.25[149] | 2.06[150] | 3.19[151] | 2.28[152] | 2.02[153] | 3.15[154] |
23 | FOXO4 | Forkhead box protein O4 | [155] | 0.25[156] | 0.38[157] | 0.67[158] | 0.08[159] | -0.16[160] | -1.05[161] |
24 | NR4A1 | Nuclear receptor subfamily 4 group A member 1 | [162] | 0.74[163] | 1.02[164] | 1.61[165] | 0.06[166] | 0.71[167] | 0.17[168] |
25 | AKT3 | RAC-gamma serine/threonine-protein kinase | [169] | -2.32[170] | -5.15[171] | -4.00[172] | 5.76[173] | 4.26[174] | 3.25[175] |
26 | FOXO6 | Forkhead box protein O6 | [176] | [177] | [178] | [179] | [180] | [181] | [182] |